Who Paid My Doc
Glen David
Interventional Pain Medicine Seattle, WA Medical Doctor
NPI 1639285182 CMS profile 808179
550 17Th Ave Fl 5, Seattle, WA 98122
General payments
$13,948
Research payments
$820
Ownership & investment interest
$0
Research they led as principal investigator
$4,000
Through program year 2025, Glen David of Seattle, WA is reported in the CMS Open Payments database as having received $13,948 across 169 general payments and $820 in research payments paid to them. Separately, studies naming them as principal investigator received $4,000 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 81st percentile of Interventional Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
8 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $807 | 17 | |
| 2024 | General | $2,185 | 24 | |
| 2023 | General | $4,237 | 17 | |
| 2022 | General | $3,144 | 25 | |
| 2021 | General | $2,359 | 25 | |
| 2021 | Research | $820 | 1 | |
| 2020 | General | $335 | 23 | |
| 2019 | General | $882 | 38 |
Beside peers
- Glen David
- Interventional Pain Medicine median
- Middle half of Interventional Pain Medicine
- National median
In program year 2025, general payments to Glen David were reported at $807. Among 1,891 Interventional Pain Medicine profiles paid that year, the median was $657 and the middle half received between $184 and $1,753.
Show as a table
| Year | Glen David | Interventional Pain Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $882 | $684 | $216–$2,079 | $163 |
| 2020 | $335 | $382 | $122–$1,109 | $114 |
| 2021 | $2,359 | $552 | $167–$1,554 | $132 |
| 2022 | $3,144 | $605 | $187–$1,924 | $149 |
| 2023 | $4,237 | $671 | $195–$1,915 | $160 |
| 2024 | $2,185 | $684 | $206–$1,837 | $164 |
| 2025 | $807 | $657 | $184–$1,753 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 5 drugsPart D claims
130
Drug cost
$1,175
Branded share of claims
0%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Gabapentin | Generic | 72 | $711 | |
| Methylprednisolone | Generic | 20 | $166 | |
| Methocarbamol | Generic | 11 | $149 | |
| Mupirocin | Generic | 13 | $104 | |
| Cephalexin | Generic | 14 | $45 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,476 Part D prescribers listed as Interventional Pain Management; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 46 billing codesPaid by Medicare
$142,982
Medicare patients
434
Services billed
1,094
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| Arthritis | 75% | |
| High blood pressure | 69% | |
| Osteoporosis | 36% | |
| Depression | 26% | |
| Ischemic heart disease | 25% | |
| Chronic kidney disease | 21% | |
| Diabetes | 19% | |
| Atrial fibrillation | 17% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
170 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Interventional Pain Medicine in Washington
Ray Baker
Interventional Pain Medicine · Kirkland, WA
Daniel Nelson
Interventional Pain Medicine · Kirkland, WA
Kyong Kim
Interventional Pain Medicine · Lakewood, WA
Hyun Hong
Interventional Pain Medicine · Olympia, WA
Kiang Yien Cheung
Interventional Pain Medicine · Tacoma, WA
Diyan Raza
Interventional Pain Medicine · Seattle, WA
Related records
Interventional Pain Medicine in Washington
Practitioners in the same specialty and state, ranked by reported value.
All Interventional Pain Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Washington
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.